Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2
- 1 August 1980
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 22 (2) , 153-164
- https://doi.org/10.1016/0010-7824(80)90059-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- NEW PROSTAGLANDIN E2 ANALOGUE FOR PREGNANCY TERMINATIONThe Lancet, 1979
- Synthesis and biological properties of 9-deoxo-16,16-dimethyl-9-methylene-PGE2Prostaglandins, 1979
- Repeated vaginal administration of 15-methyl PGF2α methyl ester for termination of pregnancy in the 13th–20th week of gestationContraception, 1977
- Mid-Trimester Abortion by Dilatation and EvacuationNew England Journal of Medicine, 1977
- Development of a vaginal suppository suitable for single administration for interruption of second trimester pregnancyContraception, 1977
- TERMINATION OF PREGNANCY WITH VAGINAL ADMINISTRATION OF 16, 16 DIMETHYL PROSTAGLANDIN E2 p‐BENZALDEHYDE SEMICARBAZONE ESTERBJOG: An International Journal of Obstetrics and Gynaecology, 1977
- Vaginally administered 16,16-dimethyl-PGE2 for the induction of midtrimester abortionProstaglandins, 1976
- Response of the midpregnant human uterus to systemic administration of 15(S)-15-methyl-prostaglandin F2αProstaglandins, 1972